Diana M. Van Den Wollenberg
Leiden, ZH 2333ZA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Improved oncolytic and immunostimulatory activity of the spontaneous jin-3 reovirus mutant in preclinical bladder cancer models.
Journal: Molecular therapy. Oncology
Published: August 18, 2025
A new adenovirus isolated from a western lowland gorilla held in captivity.
Journal: Virology
Published: May 21, 2025
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Journal: Cancer immunology research
Published: June 08, 2023
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.
Journal: Cancer research communications
Published: January 12, 2023
Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus 'GoraVir' in Cultured Pancreatic Cancer Cells.
Journal: Viruses
Published: December 20, 2022
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines.
Journal: International journal of molecular sciences
Published: November 27, 2022
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.
Journal: Journal for immunotherapy of cancer
Published: May 20, 2022
Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-α/β Receptor Signaling.
Journal: Human gene therapy
Published: August 18, 2021
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.
Journal: Cancer gene therapy
Published: February 13, 2021
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: September 15, 2020
Last Updated: 09/26/2026